A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. Before market open, ...

At Microsoft Build 2025, we announced the public preview of SQL Server 2025. Built on a foundation of best-in-class security, performance, and availability, SQL Server 2025 empowers customers to ...

Organizations are using generative AI to stay ahead of the competition, but the real advantage lies in harnessing the power of your own data securely and at scale. One of the most exciting new ...

Hello there! 👋 I'm Luca, a BI Developer with a passion for all things data, Proficient in Python, SQL and Power BI ...

Natural language interface to databases is a growing focus within artificial intelligence, particularly because it allows users to interact with structured databases using plain human language. This ...

Recursion Pharmaceuticals' stock has been volatile, and is soaring today on news the FDA is planning on phasing out some animal testing, replacing it with AI. The company's Q4 FY24 earnings showed ...

Abstract: SQL:1999 recursive queries are almost a quarter century old. In this standard the recursive queries have the form of recursive common table expressions. In recent years vendors of almost all ...